BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38073018)

  • 1. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
    Borst AJ; Eng W; Griffin M; Ricci KW; Engel E; Adams DM; Dayneka J; Cohen-Cutler SJ; Andreoli SM; Wu MD; Wheeler AP; Heym KM; Crary SE; Nakano TA; Schulte RR; Setty BA; McLean TW; Pahl KS; Intzes S; Pateva I; Teitelbaum M; Zong Z; Li Y; Jeng MR
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30779. PubMed ID: 38073018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
    Cashell J; Smink GM; Helm K; Xavier F
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
    Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
    Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
    Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
    Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
    Wang H; Guo X; Duan Y; Zheng B; Gao Y
    Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
    Peng S; Yang K; Xu Z; Chen S; Ji Y
    J Paediatr Child Health; 2019 Sep; 55(9):1119-1124. PubMed ID: 30604513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of kaposiform hemangioendothelioma and tufted angioma.
    Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
    Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial.
    Yao W; Li K; Wang Z; Wang J; Ji Y; Zhou L; Huang H; Gao X; Huang Z; Gu S; Yang H; Zheng S
    J Dermatol; 2021 May; 48(5):576-584. PubMed ID: 33608936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
    Croteau SE; Gupta D
    Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
    Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
    [No Abstract]   [Full Text] [Related]  

  • 14. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
    Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
    Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma.
    Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P
    J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
    Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
    Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
    Zaidi SJ; Shaik S; Agrawal C; Cossor W
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey.
    Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC
    J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
    Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
    Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.